Loss of Nmp4 optimizes osteogenic metabolism and secretion to enhance bone quality.
Ontology highlight
ABSTRACT: A goal of osteoporosis therapy is to restore lost bone with structurally sound tissue. Mice lacking the transcription factor nuclear matrix protein 4 (Nmp4, Zfp384, Ciz, ZNF384) respond to several classes of osteoporosis drugs with enhanced bone formation compared with wild-type (WT) animals. Nmp4-/- mesenchymal stem/progenitor cells (MSPCs) exhibit an accelerated and enhanced mineralization during osteoblast differentiation. To address the mechanisms underlying this hyperanabolic phenotype, we carried out RNA-sequencing and molecular and cellular analyses of WT and Nmp4-/- MSPCs during osteogenesis to define pathways and mechanisms associated with elevated matrix production. We determined that Nmp4 has a broad impact o
SUBMITTER: Shao Y
PROVIDER: S-EPMC6580174 | biostudies-literature | 2019 May
REPOSITORIES: biostudies-literature
ACCESS DATA